Inga Petersen
Researcher at Department of Pharmacy; Biopharmaceuticals; ProDDe
- E-mail:
- inga.petersen@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Download contact information for Inga Petersen at Department of Pharmacy; Biopharmaceuticals; ProDDe
Publications
Recent publications
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Frontiers in Pharmacology, 2025
- DOI for Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Download full text (pdf) of Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Scientific Reports, 2024
- DOI for A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Download full text (pdf) of A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
Part of mAbs, 2023
- DOI for Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
- Download full text (pdf) of Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
All publications
Articles in journal
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Frontiers in Pharmacology, 2025
- DOI for Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Download full text (pdf) of Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Part of Scientific Reports, 2024
- DOI for A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Download full text (pdf) of A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
Part of mAbs, 2023
- DOI for Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
- Download full text (pdf) of Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates